These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31560814)

  • 21. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
    Ramírez-Prada J; Robledo SM; Vélez ID; Crespo MDP; Quiroga J; Abonia R; Montoya A; Svetaz L; Zacchino S; Insuasty B
    Eur J Med Chem; 2017 May; 131():237-254. PubMed ID: 28329730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and development of the covalent hydrates of trifluoromethylated pyrazoles as riboflavin synthase inhibitors with antibiotic activity against Mycobacterium tuberculosis.
    Zhao Y; Bacher A; Illarionov B; Fischer M; Georg G; Ye QZ; Fanwick PE; Franzblau SG; Wan B; Cushman M
    J Org Chem; 2009 Aug; 74(15):5297-303. PubMed ID: 19545132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of pyrazole encompassing 2-pyridone derivatives as antibacterial agents.
    Desai NC; Rajpara KM; Joshi VV
    Bioorg Med Chem Lett; 2013 May; 23(9):2714-7. PubMed ID: 23511017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, antimicrobial activity and molecular modeling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazoles.
    Menozzi G; Merello L; Fossa P; Schenone S; Ranise A; Mosti L; Bondavalli F; Loddo R; Murgioni C; Mascia V; La Colla P; Tamburini E
    Bioorg Med Chem; 2004 Oct; 12(20):5465-83. PubMed ID: 15388173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-(1H-indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump inhibitors.
    Hequet A; Burchak ON; Jeanty M; Guinchard X; Le Pihive E; Maigre L; Bouhours P; Schneider D; Maurin M; Paris JM; Denis JN; Jolivalt C
    ChemMedChem; 2014 Jul; 9(7):1534-45. PubMed ID: 24677763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target.
    Bhakta S; Besra GS; Upton AM; Parish T; Sholto-Douglas-Vernon C; Gibson KJ; Knutton S; Gordon S; DaSilva RP; Anderton MC; Sim E
    J Exp Med; 2004 May; 199(9):1191-9. PubMed ID: 15117974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Flexible Analogues of 8-Aza-7-deazapurine Nucleosides as Potential Antibacterial Agents.
    Khandazhinskaya A; Eletskaya B; Mironov A; Konstantinova I; Efremenkova O; Andreevskaya S; Smirnova T; Chernousova L; Kondrashova E; Chizhov A; Seley-Radtke K; Kochetkov S; Matyugina E
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and characterization of a novel class of pyrazolopyrimidinedione tRNA synthesis inhibitors.
    Montgomery JI; Smith JF; Tomaras AP; Zaniewski R; McPherson CJ; McAllister LA; Hartman-Neumann S; Arcari JT; Lescoe M; Gutierrez J; Yuan Y; Limberakis C; Miller AA
    J Antibiot (Tokyo); 2015 Jun; 68(6):361-7. PubMed ID: 25464974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragment-Based Whole Cell Screen Delivers Hits against M. tuberculosis and Non-tuberculous Mycobacteria.
    Moreira W; Lim JJ; Yeo SY; Ramanujulu PM; Dymock BW; Dick T
    Front Microbiol; 2016; 7():1392. PubMed ID: 27656168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, characterization and pharmacological screening of some novel 5-imidazopyrazole incorporated polyhydroquinoline derivatives.
    Kalaria PN; Satasia SP; Raval DK
    Eur J Med Chem; 2014 May; 78():207-16. PubMed ID: 24681985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives.
    Zampieri D; Mamolo MG; Laurini E; Scialino G; Banfi E; Vio L
    Bioorg Med Chem; 2008 Apr; 16(8):4516-22. PubMed ID: 18321714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminoguanidine hydrazones (AGH's) as modulators of norfloxacin resistance in Staphylococcus aureus that overexpress NorA efflux pump.
    Dantas N; de Aquino TM; de Araújo-Júnior JX; da Silva-Júnior E; Gomes EA; Gomes AAS; Siqueira-Júnior JP; Mendonça Junior FJB
    Chem Biol Interact; 2018 Jan; 280():8-14. PubMed ID: 29208359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth.
    Chollet A; Mori G; Menendez C; Rodriguez F; Fabing I; Pasca MR; Madacki J; Korduláková J; Constant P; Quémard A; Bernardes-Génisson V; Lherbet C; Baltas M
    Eur J Med Chem; 2015 Aug; 101():218-35. PubMed ID: 26142487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
    Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological activity of alkynoic acids derivatives against mycobacteria.
    Vilchèze C; Leung LW; Bittman R; Jacobs WR
    Chem Phys Lipids; 2016 Jan; 194():125-38. PubMed ID: 26256431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents.
    Garg S; Shakya N; Srivastav NC; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2016 Nov; 24(21):5521-5533. PubMed ID: 27665179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents.
    Türe A; Kulabaş N; Dingiş Sİ; Birgül K; Bozdeveci A; Alpay Karaoğlu Ş; Krishna VS; Sriram D; Küçükgüzel İ
    Bioorg Chem; 2019 Jul; 88():102965. PubMed ID: 31085371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.